Integer - ITGR Stock Forecast, Price & News

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Integer Price Performance

Shares of ITGR traded up $1.19 during trading hours on Thursday, reaching $73.64. The company had a trading volume of 5,056 shares, compared to its average volume of 145,642. The company has a current ratio of 2.70, a quick ratio of 1.71 and a debt-to-equity ratio of 0.68. The firm has a 50 day simple moving average of $70.74 and a 200-day simple moving average of $76.41. Integer has a 12-month low of $64.95 and a 12-month high of $100.71. The company has a market capitalization of $2.44 billion, a price-to-earnings ratio of 31.09 and a beta of 1.21.

Integer (NYSE:ITGR - Get Rating) last announced its quarterly earnings results on Thursday, July 28th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.18 by ($0.14). Integer had a net margin of 6.10% and a return on equity of 9.50%. The business had revenue of $350.10 million during the quarter, compared to analysts' expectations of $343.57 million. During the same period last year, the company earned $1.07 EPS. The firm's revenue for the quarter was up 12.2% on a year-over-year basis. Research analysts expect that Integer will post 4.3 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on ITGR. KeyCorp reduced their price objective on Integer from $109.00 to $97.00 and set an "overweight" rating on the stock in a research note on Friday, July 29th. StockNews.com downgraded shares of Integer from a "buy" rating to a "hold" rating in a report on Monday, April 25th. Finally, TheStreet downgraded shares of Integer from a "b-" rating to a "c+" rating in a research note on Friday, May 13th.